Crohn’s & Colitis Foundation Perspectives-logo

Crohn’s & Colitis Foundation Perspectives

ReachMD

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
More Information

Location:

United States

Networks:

ReachMD

Description:

As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis. With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD. The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.

Language:

English


Episodes

Highlights from the Crohn’s & Colitis Foundation Perspectives Series

5/22/2018
More
Hear from experts, patients, and caregivers as they discuss the latest in IBD in the Crohn’s & Colitis Foundation Perspectives series.

Duration:00:01:00

A Message from the President & CEO of Crohn’s & Colitis Foundation

5/22/2018
More
Hear from Michael Osso, President and CEO of the Crohn’s & Colitis Foundation, as he talks about the Crohn’s & Colitis Foundation Perspectives series on ReachMD.

Duration:00:00:30

IBD Expert Panel: When is the Right Time to Refer to GI?

4/11/2018
More
Host: Brian P. McDonough, MD, FAAFP Guest: John D. Betteridge, MD Guest: Philip Stein, MD Guest: Thomas Judge, M.D. From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough moderates an expert gastroenterology panel exploring some of the top issues in IBD management: the best time for primary care clinicians to refer patients to GI, challenges to making an early diagnosis, and differences between IBD and IBS. Panel participants include: Dr. John Betteridge,...

Duration:00:20:59

The Crohn’s & Colitis Foundation's Camp Oasis: A Patient's Perspective

4/11/2018
More
Host: Philip Stein, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Claire Griffin and Bill Johnson, patients and counselors at CCF's Camp Oasis. Claire and Bill discuss their respective involvements with the camp, why they made the decision to go, how they became their own personal advocates, and what Camp Oasis taught them about adjusting to their disease.

Duration:00:09:29

The Crohn’s & Colitis Foundation's Camp Oasis: A Clinician's Perspective

4/11/2018
More
Host: Philip Stein, MD Guest: Neilanjan Nandi, MD, FACP Guest: Susan Peck, MSN, CRNP From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Philip Stein talks with Dr. Neilanjan Nandi and nurse practitioner Susan Peck about their respective experiences with The Crohn’s & Colitis Foundation's Camp Oasis. This camp gives children with IBD the opportunity to meet other kids with the same chronic illness, teaching them how to cope with their disease, manage their own...

Duration:00:09:29

Travel for IBD Patients: How to Help Them Prepare

4/11/2018
More
Host: Adam Ehrlich, MD, MPH Guest: Adam Kaufman, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Adam C. Ehrlich talks with Dr. Adam Kaufman, Gastroenterologist at Main Line Gastroenterology Associates. Dr. Kaufman brings to the forefront the importance of preparing your IBD patient for travel. Discussion points include scheduling a pre-travel counsel visit, medication choices and proper storage procedures, vaccination considerations, blood clot prophylaxis, and...

Duration:00:10:29

IBD and Intimacy: Managing an Under-Recognized Issue

4/11/2018
More
Host: Robert Frankel, MD Guest: Neilanjan Nandi, MD, FACP From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Robert Frankel talks with Dr. Neilanjan Nandi, Assistant Professor in the Division of Gastroenterology & Hepatology and Associate Director of the Gastroenterology Fellowship program at Drexel University College of Medicine. Dr. Nandi shares new insights on how to approach sexual and intimacy issues for IBD patients. Discussion points include quality of life...

Duration:00:11:59

IBD Preventive Care: Clinical Priorities for Best Patient Outcomes

4/11/2018
More
Host: Brian P. McDonough, MD, FAAFP Guest: Adam Ehrlich, MD, MPH Guest: John D. Betteridge, MD From the ReachMD studios in Fort Washington, Pennsylvania, host Dr. Brian McDonough leads an expert panel focusing on preventive care for IBD patients. Joining the expert panel are: Dr. Adam C. Ehrlich, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Co-Medical Director of the Temple Inflammatory Bowel Disease Program, and Dr. John D. Betteridge,...

Duration:00:14:59

Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance

1/1/2018
More
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance. Liefferinckx C1, Minsart C, Toubeau JF, Cremer A, Amininejad L, Quertinmont E, Devière J, Gils A, van Gossum A, Franchimont D. BACKGROUND: Infliximab (IFX) is indicated for the treatment of inflammatory bowel diseases (IBD). Nevertheless, loss of response (LOR) to IFX is reported in up to 10% to 30% of patients within the first year of treatment. Our objective was to evaluate the impact of the...

Duration:00:04:29

Anemia Care for IBD Patients

2/26/2017
More
Patients with inflammatory bowel diseases (IBD) are at a greater risk of developing anemia, a common complication that affects their quality of life and is associated with high rates of other IBD-related complications. Host Laura Wingate, Vice President of Education, Support and Advocacy for the Crohn's & Colitis Foundation, chats with Dr. Jason Hou, Assistant Professor of Gastroenterology at Baylor College of Medicine about gaps in the importance of anemia management, diagnostics, and...

Duration:00:12:00

Hospital Management of Severe Colitis: Utilization of Medical Rescue Therapies

2/26/2017
More
Severe ulcerative colitis continues to cause frequent medical emergencies requiring hospitalization for optimal management. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, discusses several medical rescue therapies for severe ulcerative colitis in the hospital setting with Dr. Adam Cheifetz, Associate Professor of Medicine at Beth Israel Deaconess Medical Center.

Duration:00:11:00

Optimizing Growth in Pediatric Inflammatory Bowel Disease

2/26/2017
More
Recorded on location at the Crohn’s & Colitis Foundation's Annual Meeting in Orlando, host Dr. Sophie Balzora, Crohn's & Colitis Foundation Reach-IBD member and faculty advisor of the Greater New York Chapter Fellows' Education Committee, discusses general strategies for clinicians and families to optimize growth in pediatric IBD with Dr. K.T. Park, Assistant Professor of Pediatric Gastroenterology at Stanford University School of Medicine & Co-Director of Stanford Children’s...

Duration:00:06:30

Biologics For Inflammatory Bowel Disease: Maximizing Benefits, Avoiding Complications

2/26/2017
More
Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses potential complications of biologics with Dr. Gary Lichtenstein, Professor of Medicine at the Hospital of the University of Pennsylvania.

Duration:00:08:30

Health Maintenance in IBD: Toward Optimum Care Plans

1/15/2017
More
Recorded on location at the Crohn’s & Colitis Foundation's Annual Meeting in Orlando, host Laura Wingate,Vice President of Education Support and Advocacy for the Crohn's & Colitis Foundation, discusses health maintenance for IBD patients with Dr. Gil Melmed, Director of the Advanced IBD Fellowship Program and Clinical Research in the Division of Gastroenterology at Cedars-Sinai Medical Center.

Duration:00:13:29

Redefining Mucosal Healing in IBD: Updated Goals of Therapy

1/10/2017
More
Recorded on location at the Crohn’s & Colitis Foundation’s Annual Meeting in Orlando, host Dr. Lea Ann Chen, Assistant Professor of Medicine at New York University, discusses goals of therapy in IBD with Dr. Hans Herfarth, Professor of Medicine at University of North Carolina School of Medicine.

Duration:00:07:30

Clinical Trials in IBD: Advancing Science, Enhancing Patient Care

12/4/2016
More
Clinical trials, among several critical purposes, are essential for the evaluation and approval of medication options for patients living with inflammatory bowel diseases. Despite this, only 6% of clinical trials are completed on time due to unfulfilled enrollment, often stemming to communication barriers between clinicians and patients. Host Dr. Caren Heller, Chief Scientific Officer at the Crohn's & Colitis Foundation, sits down with Dr. William Sandborn, Professor of Medicine and...

Duration:00:24:00

Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations

10/30/2016
More
Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study Law, Cindy C. Y. MD; Sasidharan, Saranya MD; Rodrigues, Rodrigo MD; Nguyen, Deanna D. MD; Sauk, Jenny MD; Garber, John MD; Giallourakis, Cosmas MD; Xavier, Ramnik MD, PhD; Khalili, Hamed MD, MPH; Yajnik, Vijay MD, PhD; Ananthakrishnan, Ashwin N. MD, MPH Host: Dr. Manish Singla, Gastroenterology Division, Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, MD...

Duration:00:03:29

Importance of Nutrition in Managing Inflammatory Bowel Disease

10/30/2016
More
From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Lindsey Albenberg, Gastroenterologist in the division of Gastroenterology, Hepatology and Nutrition at the Children's Hospital of Philadelphia, about the value of nutrition in managing inflammatory bowel disease.

Duration:00:12:00

Inflammatory Bowel Disease: Key Signs and Symptoms

10/30/2016
More
From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Adam Kaufman, Gastroenterologist, and internist at Mainline Gastroenterology Associates, about the signs and symptoms of Inflammatory Bowel Disease.

Duration:00:11:30

Latest Pediatric Research on IBD in Children

10/30/2016
More
From the Crohn's & Colitis Foundation's Take Steps Walk in Philadelphia, host Rhondell Domilici talks with Dr. Judith Kelsen, attending physician in the Division of Gastroenterology, Hepatology and Nutrition at the Children's Hospital of Philadelphia, about Crohn's Disease and Ulcerative Colitis in the pediatric population, and the latest research in IBD from this field.

Duration:00:11:00